Please ensure Javascript is enabled for purposes of website accessibility

Medical Pot Dispensaries Exempt From New Colorado Stay-at-Home Order

By Eric Volkman - Mar 27, 2020 at 5:35PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medical marijuana stores fall under the category of "critical businesses," as defined in the order.

Colorado, a bellwether state for marijuana legalization, is exempting dispensaries selling medical product from its latest "stay at home" order.

Similar to other states, Colorado has mandated its residents to remain in their homes in an attempt to quell the spread of the SARS-CoV-2 coronavirus. There's a set of exceptional circumstances in which people can venture outside, such as for grocery or medicine shopping... or the purchase of medical marijuana.

This form of the drug is classified under the category of "critical businesses" -- i.e., those deemed essential to maintaining the health and safety of Coloradans. Recreational cannabis, however, is not covered under the order.

Welcome to Colorado road sign with marijuana leaf.

Image source: Getty Images.

People venturing out to buy medical weed or other goods sold by critical businesses are required to observe social distancing requirements. As per established standards, this means keeping a distance of at least six feet from other individuals, among other measures.

Along with Washington, Colorado was among the first two states legalizing recreational marijuana (in 2012). Previously, it had sanctioned medical cannabis in 2000. The industry is thriving: Official statistics show that 2019 was a record year for it in the state, with almost $1.75 billion in sales.

Many cannabis companies have a presence in Colorado. One that's sure to benefit from the continued access to customers is Curaleaf (CURLF 1.24%), which earlier this month announced the acquisition of premium edibles-maker BlueKudu, based in the state. BlueKudu makes a line of medical cannabis products, sales of which should help Curaleaf's top line once the buyout closes.

Curaleaf's stock rose briskly on Friday, closing nearly 9% higher. That was in stark contrast to the broader share indexes, which nearly all fell on the day.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$6.05 (1.24%) $0.07

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.